Note 11 - Net Loss Per Share Attributable to Common Stockholders - Anti-dilutive Securities (Details) - shares shares in Thousands		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020
Potentially dilutive common shares (in shares)		46,705	31,609
Unvested Stock [Member]
Potentially dilutive common shares (in shares)	[1]	1,662	916
Convertible Preferred Stocks [Member]
Potentially dilutive common shares (in shares)		30,754	16,635
Common Stock Warrants [Member]
Potentially dilutive common shares (in shares)		2,207	1,976
IPO Warrants [Member]
Potentially dilutive common shares (in shares)	[2]	12,082	12,082

[1] Does not include 8.3 million shares for each of the three and nine months ended September 30, 2021 and 3.0 million shares for each of the three and nine months ended September 30, 2020, of unvested stock because the performance conditions had not yet been satisfied as of September 30, 2021 and 2020, respectively.

[2] The IPO Warrants were issued in connection with our initial public offering in 2015. The IPO Warrants are exercisable at a price of $11.50 per share and expire on July 24, 2022. The Company may redeem the IPO Warrants at a price of $0.01 per IPO Warrant upon 30 days' notice only if the last sale price of our common stock is at least $17.50 per share for any 20 trading days within a 30 trading day period. If the Company redeems the IPO Warrants in this manner, the Company will have the option to do so on a cashless basis with the issuance of an economically equivalent number of shares of Company common stock.